Preview Mode Links will not work in preview mode

Jun 29, 2022

Featuring perspectives from Drs Ian Flinn, Brian Hill, John Leonard, Matthew Lunning, Laurie Sehn and Mitchell Smith, including the following topics:

  • Introduction (0:00)
  • Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) — Ian W Flinn, MD, PhD (3:07)
  • Relapsed/Refractory CLL; Novel Investigational Strategies...


Jun 20, 2022

Featuring perspectives from Drs Courtney DiNardo, Michael Savona and Eunice Wang, including the following topics:

  • Introduction (0:00)
  • Selection of therapy for older and younger patients with acute myeloid leukemia (AML) (2:05)
  • Therapy for patients with AML with targetable mutations (33:42)
  • Current and future management...


Jun 16, 2022

Featuring perspectives from Dr John Mascarenhas, including the following topics:
Introduction (0:00)

  • Case: A man in his mid 60s with post-PV myelofibrosis (MF) and ASXL1 and SRSF2 mutations — Jeanne Palmer, MD (22:40)
  • Case: A woman in her early 70s with high-risk primary MF and a CALR mutation (28:34)
  • Case: A woman...


Jun 14, 2022

Featuring perspectives from Ms Lesley Camille Ballance, Ms Amy Goodrich, Dr Lowell Hart and Dr Anthony Mato, including the following topics:

  • Introduction (0:00)
  • Overview of Chronic Lymphocytic Leukemia (5:47)
  • Bruton Tyrosine Kinase Inhibitors (27:40)
  • Venetoclax and Anti-CD20 Antibody Therapy (58:59)
  • Future Strategies...


Jun 10, 2022

Featuring perspectives from Ms Ilene Galinsky and Dr Eunice Wang, including the following topics:

  • Introduction (0:00)
  • Younger patients with acute myeloid leukemia (AML) (2:11)
  • Older patients with AML (34:45)
  • Treatment for myelodysplastic syndromes (49:57)

NCPD information and select publications